Inborn errors of metabolism associated with autism spectrum disorders: approaches to intervention

T Žigman, D Petković Ramadža, G Šimić… - Frontiers in …, 2021 - frontiersin.org
Increasing evidence suggests that the autism spectrum disorder (ASD) may be associated
with inborn errors of metabolism, such as disorders of amino acid metabolism and transport …

Acute intermittent porphyria: an overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators

HJ Bustad, JP Kallio, M Vorland, V Fiorentino… - International Journal of …, 2021 - mdpi.com
Acute intermittent porphyria (AIP) is an autosomal dominant inherited disease with low
clinical penetrance, caused by mutations in the hydroxymethylbilane synthase (HMBS) …

Givosiran for the treatment of acute hepatic porphyria

A Ricci, P Ventura - Expert Review of Clinical Pharmacology, 2022 - Taylor & Francis
ABSTRACT Introduction Acute hepatic porphyrias (AHPs) are a family of rare inherited
disorders characterized by enzyme dysfunctions in the hepatic pathway of heme …

The use of pharmacological chaperones in rare diseases caused by reduced protein stability

J Gil‐Martínez, G Bernardo‐Seisdedos, JM Mato… - …, 2022 - Wiley Online Library
Rare diseases are most often caused by inherited genetic disorders that, after translation,
will result in a protein with altered function. Decreased protein stability is the most frequent …

RNA interference therapy in acute hepatic porphyrias

M Yasuda, S Keel, M Balwani - Blood, 2023 - ashpublications.org
The acute hepatic porphyrias (AHPs) are inherited disorders of heme biosynthesis
characterized by life-threatening acute neurovisceral attacks precipitated by factors that …

[HTML][HTML] Acute intermittent porphyria's symptoms and management: a narrative review

EZ Kizilaslan, NM Ghadge, A Martinez, M Bass… - Cureus, 2023 - ncbi.nlm.nih.gov
Acute intermittent porphyria (AIP) is an autosomal dominant disorder of heme biosynthesis
in the liver that is caused by the accumulation of toxic heme metabolites aminolevulinic acid …

[HTML][HTML] Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid

S Sansaloni-Pastor, E Varesio, N Lange - Journal of Photochemistry and …, 2022 - Elsevier
ALA-mediated photodynamic therapy (PDT) has been developed around the heme
biosynthesis physiological pathway. It is based on the external supplementation of 5 …

Givosiran, a novel treatment for acute hepatic porphyrias

M Thapar, S Rudnick, HL Bonkovsky - Expert Review of Precision …, 2021 - Taylor & Francis
ABSTRACT Introduction Acute hepatic porphyrias (AHPs) are a group of rare genetic
disorders that affect the enzymes of the heme biosynthetic pathway. Patients have a varied …

Exploring current and emerging therapies for porphyrias

D Jericó, KM Córdoba, F Urigo… - Liver …, 2024 - Wiley Online Library
Porphyrias are rare, mostly inherited disorders resulting from altered activity of specific
enzymes in the haem synthesis pathway that lead to accumulation of pathway intermediates …

Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs

O Balogun, K Nejak-Bowen - Seminars in Liver Disease, 2024 - thieme-connect.com
Hepatic porphyrias are a group of metabolic disorders that are characterized by
overproduction and accumulation of porphyrin precursors in the liver. These porphyrins …